BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 27637760)

  • 1. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
    Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
    Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.
    Carrade Holt DD; Wood JA; Granick JL; Walker NJ; Clark KC; Borjesson DL
    Stem Cells Dev; 2014 Jun; 23(11):1258-65. PubMed ID: 24438346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
    Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
    Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.
    Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A
    Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.
    Li CY; Wu XY; Tong JB; Yang XX; Zhao JL; Zheng QF; Zhao GB; Ma ZJ
    Stem Cell Res Ther; 2015 Apr; 6(1):55. PubMed ID: 25884704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose-derived stromal cells cultured in a low-serum medium, but not bone marrow-derived stromal cells, impede xenoantibody production.
    Saka Y; Furuhashi K; Katsuno T; Kim H; Ozaki T; Iwasaki K; Haneda M; Sato W; Tsuboi N; Ito Y; Matsuo S; Kobayashi T; Maruyama S
    Xenotransplantation; 2011; 18(3):196-208. PubMed ID: 21696449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression.
    Stanko P; Kaiserova K; Altanerova V; Altaner C
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):373-7. PubMed ID: 24145770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
    Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
    Stem Cell Rev Rep; 2015 Jun; 11(3):442-52. PubMed ID: 25326368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of equine bone marrow and adipose tissue-derived mesenchymal stromal cells.
    Ranera B; Ordovás L; Lyahyai J; Bernal ML; Fernandes F; Remacha AR; Romero A; Vázquez FJ; Osta R; Cons C; Varona L; Zaragoza P; Martín-Burriel I; Rodellar C
    Equine Vet J; 2012 Jan; 44(1):33-42. PubMed ID: 21668489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M; Masoud A; Shakiba Y; Hadjati J; Mohyeddin Bonab M; Nicknam MH; Latifpour M; Nikbin B
    Iran J Allergy Asthma Immunol; 2013 Mar; 12(1):37-49. PubMed ID: 23454777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.
    Ivanova-Todorova E; Bochev I; Mourdjeva M; Dimitrov R; Bukarev D; Kyurkchiev S; Tivchev P; Altunkova I; Kyurkchiev DS
    Immunol Lett; 2009 Sep; 126(1-2):37-42. PubMed ID: 19647021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
    Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
    Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
    de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
    Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.
    Russell KA; Chow NH; Dukoff D; Gibson TW; LaMarre J; Betts DH; Koch TG
    PLoS One; 2016; 11(12):e0167442. PubMed ID: 27907211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.